Camelot Portfolios’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Camelot Portfolios's JNJ Position: Q1 2026 in Review
Camelot Portfolios sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 424 shares — an estimated $87.7K sold.
Camelot Portfolios first reported a position in JNJ in Q2 2013 and held it in 18 quarters. The position peaked at $2.25M in Q2 2013. 4,641 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Camelot Portfolios reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
- Camelot Portfolios sold 424 Johnson & Johnson shares in Q1 2026, an estimated $87.7K.
- Camelot Portfolios first reported a position in Johnson & Johnson in Q2 2013 and held it in 18 quarters.
- Camelot Portfolios's Johnson & Johnson position peaked at $2.25M in Q2 2013.
- 4,641 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Camelot Portfolios's 13F filing for Q1 2026, filed 8 May 2026.